Table 1.
Measure | All patients, N = 242 |
---|---|
Sex, n (%) | |
Male | 123 (51) |
Female | 119 (49) |
Median age (range), y | 57.8 (9.3-79.6) |
White, n (%) | |
Yes | 182 (75) |
No | 60 (25) |
Diagnosis, n (%) | |
AML | 206 (85) |
MDS/AML | 23 (10) |
MPD/AML | 10 (4) |
MDS | 3 (1) |
Disease status at MUD search, n (%) | |
Remission | 113 (47) |
Not in remission | 128 (53) |
Missing | 1 (0.4) |
Reason not in remission, n (%) | |
PIF | 35 (28) |
Relapsed/refractory | 43 (34) |
Newly diagnosed | 50 (39) |
Haplotype frequency, n (%) | |
Common | 190 (79) |
Uncommon | 52 (21) |
10/10 MUD identified, n (%) | |
Yes | 160 (66) |
No | 82 (34) |
Transplant type, n (%) | |
MUD | 85 (35) |
Other | 66 (27) |
None | 91 (38) |
Reason for not receiving a transplant, n (%) | |
Disease progression | 36 (15) |
Refractory | 19 (8) |
Other | 36 (15) |
Median time to SCT from MUD search date (range), mo | |
10/10 MUD (n = 85) | 2.9 (1.4-13.0) |
MRD (n = 15) | 2.3 (1.6-6.4) |
9/10 MUD (n = 9) | 4.6 (3.7-13.1) |
Haploidentical (n = 20) | 3.5 (0.9-13.4) |
UCB (n = 22) | 3.2 (1.7-14.7) |
MPD, myeloproliferative disorder; SCT, stem cell transplant.